Bill Snyder

October 9, 2014

Longaker set for Discovery Lecture

Michael Longaker, M.D., well known for his contributions to tissue repair and engineering and stem cell biology at Stanford University School of Medicine, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 16.

By Bill Snyder
Cholesterol
October 2, 2014

Team spots key regulator for cholesterol production

A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223.

By Bill Snyder
October 2, 2014

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.

By Bill Snyder
September 25, 2014

VUMC well positioned to move forward: Balser

By Bill Snyder
September 24, 2014

Alexander’s visit highlights efforts to confront Ebola

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

By Bill Snyder
September 24, 2014

Alexander’s visit highlights efforts to confront Ebola

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

By Bill Snyder
September 18, 2014

Initiative seeks to develop therapies to combat Ebola

Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.
By Bill Snyder
September 12, 2014

Schizophrenia ‘switches’ discovered

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.
By Bill Snyder
September 11, 2014

Meeting explores VUMC’s cultural renaissance

During presentations that were filled with messages about Vanderbilt University Medical Center’s purpose, addressing the “why” rather than detailing facts and figures, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, and C. Wright Pinson, MBA, M.D., deputy vice chancellor for Health Affairs and CEO of the Vanderbilt Health System, led the audience at Wednesday’s Fall Leadership Assembly through candid dialogue about VUMC’s way forward.
By Bill Snyder
September 11, 2014

Study tracks new way to fight HIV infection in women

Vanderbilt University’s Richard Caprioli, Ph.D., is participating in a national, federally funded collaboration to develop an intravaginal ring capable of delivering antiretroviral drugs to women at risk for HIV infection.
By Bill Snyder
September 4, 2014

Foundation grants bolster autism, dystonia research

Vanderbilt University researchers have received multi-year grants from two private foundations to investigate key signaling proteins that could lead to novel treatments for autism spectrum disorder (ASD) and dystonia, a movement disorder.
By Bill Snyder
September 4, 2014

Science educations bloom from ‘Simple Beginnings’

Vanderbilt University welcomed 99 new doctoral students last Friday, Aug. 29, during the fifth annual “Simple Beginnings” ceremony in a Light Hall lecture room packed with family members and other well-wishers.
By Bill Snyder
1 … 86 87 88 89 90 … 110